viernes, 23 de febrero de 2018

February Women's Health Update: Heart Health Resources, New Pregnancy Blog and more

For Women

FDA Header

Participate in Upcoming Meetings
Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC)
The 21st Century Cures Act established PRGLAC to advise the Secretary of Health and Human Services regarding gaps in knowledge and research on safe and effective therapies for pregnant women and lactating women. PRGLAC is tasked with identifying these gaps and will report its findings back to the Secretary.
February 26, 2018, 8:30 am to 5:00 pm (EST)
February 27, 2018, 8:00 am to 3:00 pm (EST)
National Institutes of Health, Bethesda, MD

Advisory Committee Meeting: Risk Communication
This meeting will discuss the impact of pregnancy and lactation labeling information in prescription drug and biological products as modified under the Pregnancy and Lactation Labeling Rule.
March 5 - 6, 2018, 8:00 am to 5:00 pm (EST)
FDA White Oak Campus, Silver Spring, MD

FDA Grand Rounds: Are Stem Cells Ready for Prime Time? A Look at FDA Research Advances in Regenerative Medicine - Webinar
March 8, 2018, 12:00 pm to 1:00 pm (EST)

Public Meeting: Promoting the Use of Complex Innovative Designs in Clinical Trials
March 20, 2018, 8:30 am to 5:00 pm (EST)
FDA White Oak Campus, Silver Spring, MD

Public Meeting: Evaluating Inclusion and Exclusion Criteria in Clinical Trials
April 16, 2018, 8:30 am to 5:00 pm (EST)
National Press Club, 529 14th St. NW, Washington, DC 20045

Public Meeting on Patient-Focused Drug Development for Opioid Use Disorder
April 17, 2018, 10:00 am to 4:00 pm (EST)
FDA White Oak Campus, Silver Spring, MD
Learn more about OWH staff presentations at national and international meetings and conferences.

No hay comentarios:

Publicar un comentario